FDA Clears Sirius Pintuition(R) for Long-term and Soft Tissue Implantation

Expanded indications further strengthen Sirius' growing Surgical Marker Navigation platform EINDHOVEN, Netherlands , Nov. 14, 2023 -- (Healthcare Sales & Marketing Network) -- In a ground-breaking development, Sirius Medical, the leader in Surgical Mar... Devices, Oncology, Surgery, FDA Sirius Medical, Pintuition, tumor marker, breast cancer
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news